Clinical Trials Logo

Filter by:
NCT ID: NCT06431386 Recruiting - Bipolar Disorder Clinical Trials

Behavioural Activation Therapy and Esketamine for Resistant Depression

Start date: June 2024
Phase: N/A
Study type: Interventional

This is a randomized clinical trial to test the effectiveness of combining a proven psychological intervention called behavioural activation therapy alongside esketamine treatment for treatment resistant major depressive episodes in individuals with major depressive disorder or bipolar disorder. Encouraging participants to practice new behaviours while their mood is improved through esketamine treatment may lead to more lasting recovery from depression.

NCT ID: NCT06430294 Recruiting - Spinal Mobilization Clinical Trials

Caracteristics of Pediatric Spinal Mobilizations

Start date: March 1, 2024
Phase:
Study type: Observational

This observational study aims to create simulations using pediatric manikins to teach pediatric spinal mobilizations. We'll measure the force and duration of spinal mobilizations applied by chiropractors on pediatric manikins. Another objective is to gather feedback from both students and teachers on the effectiveness of using manikins for teaching. The main questions it aims to answer are: 1. How much force and for how long do chiropractors apply spinal mobilizations on pediatric manikins?

NCT ID: NCT06430281 Recruiting - Manual Therapy Clinical Trials

Manual Therapy Force Perception Scale

Start date: February 1, 2024
Phase:
Study type: Observational

The objective of this observational study is to pilot a scale designed to assist clinicians in evaluating the force they perceive during manual therapy. The main question it aims to answer is: - Are clinicians able to evaluate the force they use when delivering manual therapies to their patients using a scale? For the pilot test, licensed chiropractors administer manual therapies on a manikin.

NCT ID: NCT06428708 Recruiting - Clinical trials for Metastatic Clear Cell Renal Cell Carcinoma

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

Start date: January 24, 2022
Phase: Early Phase 1
Study type: Interventional

Staging of kidney cancer is primarily achieved by computerized tomography (CT) scans or magnetic resonance imaging (MRI). If a patient is found to have limited metastatic disease, surgical removal or radiation therapy could be considered in order to control the majority of the disease. However, if metastases are more widespread, systemic (drug) therapy may be the preferred management option. The identification of additional metastatic sites using more sensitive imaging modalities therefore has the potential to alter management, and this remains an unmet need in the field. This study will investigate the utility of positron emission tomography (PET) imaging with PSMA (prostate specific membrane antigen). Kidney cancer of the clear cell subtype has demonstrated high expression of PSMA, making it a disease in which PSMA-targeted PET imaging could help to identify occult metastatic disease.

NCT ID: NCT06428214 Recruiting - Chin Augmentation Clinical Trials

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

ARTIST
Start date: May 13, 2024
Phase: N/A
Study type: Interventional

The study's main purpose is to evaluate the overall aesthetic improvement of the treated areas by treatment group, as assessed by the Investigator.

NCT ID: NCT06423118 Recruiting - Aging Clinical Trials

Sleep Apnea and Cognition in Older Adults

Start date: April 9, 2024
Phase:
Study type: Observational

The goal of this cross-sectional, observational, medical device trial is to examine the association of several sleep parameters, including specific respiratory events and an apnea-hypopnea index, with cognitive performance in older adults. The main question the study aims to answer is: Is there an association between sleep parameters with cognitive performance? Researchers will collect sleep parameters from participants using a device called the ANNE Vital Sign System and will test whether they are associated with performance on different memory and thinking tasks. Participants will: Complete a battery of cognitive tests to assess their memory and thinking performance. Wear the ANNE Vital Sign System continuously for a period of 24 hours.

NCT ID: NCT06420739 Recruiting - Fasting Clinical Trials

The Semaglutide Study

Start date: March 25, 2024
Phase:
Study type: Observational

The primary goal of this study is to evaluate the incidence of "full stomach" in fasting elective surgical patients on Semaglutide medication. The other goals are to study the impact of the time interval since the last dose of the medication on the incidence of full stomach and to develop evidence-based recommendations for the perioperative management of these patients.

NCT ID: NCT06420518 Recruiting - type1diabetes Clinical Trials

Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy.

CKM 1
Start date: April 30, 2024
Phase:
Study type: Observational

The goal of this 14-day randomized pilot trial is to assess the accuracy of a continuous ketone monitoring (CKM) system when compared to standard point-of-care capillary ketone monitors in individuals with type 1 diabetes on insulin pump therapy. The main question it aims to answer is: - Can a CKM system demonstrate equivalent ketone monitoring compared to a capillary ketone monitor with accuracy within a mean absolute difference of no more than ± 0.1 mmol/L. Participants will be asked to wear the SiBio KS1 CKM system for 14-days while undergoing two sequential ketogenic diets which are interspaced by an inpatient insulin-suspension period.

NCT ID: NCT06419257 Recruiting - Advance Dementia Clinical Trials

Investigating the Efficacy of an Augmented Virtual Reality Driving Simulator on Institutionalized Dementia Patients

Start date: January 2, 2024
Phase: N/A
Study type: Interventional

The improvement in health and welfare in modern society has led to an increase in life expectancy. Alternatively, the longer one lives, the more likely to experience deterioration in memory, cognitive ability, and executive function skills in our brains. While some cognitive impairments can be typical results of normal aging, a decline in spatial cognition can be a sign of dementia, especially Alzheimer's disease (AD). Based on the neuroplasticity of the brain even at old ages, there are some hopes to combat dementia by repeated use of cognitive exercises in the form of a serious game designed for older adults. A popular new technology to be used to design serious games is virtual reality (VR) designs. Aside from the gaming applications, the focus of VR experiments in medicine and neuroscience is to simulate a naturalistic environment to investigate brain function and/or use it for cognitive training. A virtual reality driving simulator (VRDS) has been developed by our team that is proposed to be installed in an existing car model at Riverview Health Center (RHC) dementia units. The VRDS has different levels of difficulty so that it can be utilized by people with different levels of cognitive impairments. However, in this study, the users will probably use only its level 1. The aim is to investigate the efficacy of the VRDS amongst institutionalized Alzheimer's/dementia patients, who are not capable of performing standard assessments. The goal is mainly to improve their mood and quality of life as many of these patients miss driving. Thus, their plausible mood change are assessed by asking the dementia unit nurses to share their observations of the patients in relation to VRDS usage; it will be a free-format anecdotal observation. In addition, while these patients are not expected to show any significant learning, playing this VRDS may improve patients' implicit memory; which can be observed by how well or poor they drive the simulated car; for example, how many times they crash to the curb or how many times they hit an animal, or how many times they ignore the red traffic light, etc.; these are reflected in the game's score. It is anticipated that this VRDS will have an overall positive effect on users' moods, and also it may result in an implicit memory improvement.

NCT ID: NCT06412367 Recruiting - Clinical trials for Postoperative Complications

FUNCTIONAL ASSESSMENT FOR SURGERY BY A TIMED WALK

FAST Walk
Start date: June 10, 2024
Phase:
Study type: Observational

The FAST Walk study aims to determine whether a walking test called the 6-minute walk test (6MWT) can help identify people who are more likely to experience complications after surgery. This test will be completed before surgery. We hope that the results of this study will help improve care for patients having major surgery in the future.